期刊文献+

肿瘤浸润淋巴细胞对直肠癌术前放疗预后的影响 被引量:1

Tumor-infiltrating lymphocytes predict efficacy of preoperative radiotherapy for rectal cancer
原文传递
导出
摘要 目的探讨直肠癌肿瘤组织内术前放疗后浸润淋巴细胞(TIL)数量改变对预后的影响。方法搜集近8年余接受30Gy分10次12d完成的术前放疗的直肠癌患者107例,分析TIL分级与术前放疗后病理消退程度及预后关系。结果直肠癌放疗前TIL1级75例,2级16例,3级16例,4级0例,术前放疗后TIL1级19例,2级43例,3级35例,4级10例。放疗后病理消退分级1级36例,2级57例,3级14例。单因素分析发现放疗前及放疗后TIL对局部病理消退影响有统计学意义(χ^2=36.80,P〈0.01;χ^2=14.00,P〈0.01);术前放疗后癌巢内TIL及病理消退对预后影响显著(χ^2=24.00,P〈0.01;χ^2=12.17,P〈0.01)。Logistic多元分析提示放疗后TIL与病理消退关系密切(χ^2=8.05,P〈0.01)。结论放疗前及放疗后TIL与直肠癌术前放疗局部病理消退相关。直肠癌术前放疗后癌巢TIL是影响生存预后的因素之一。 Objective To evaluate the effect of tumor infiltrating lymphocyte(TIL) on prognosis of rectal cancer treated with preoperative radiotherapy. Methods From Jan. 1999 to Oct. 2007,107 patients with rectal cancer were treated with preoperative radiotherapy of 30 Gy/10f/12 days. The relationships among TIL, pathologic regression and prognosis were analyzed. Results Before radiotherapy, TIL in rectal cancer was 75 patients (70.1%) in grade 1,16 ( 15.0% ) in grade 2 and 16 ( 15.0% ) in grade 3 ;While after radiotherapy,it changed to 19 (17.7%) in grade 1,43 (40.2%) in grade 2,35 (32.7%) in grade 3 and 10 ( 9.3% ) in grade 4. After radiotherapy, pathologic regression was 36 ( 33.6% ) in grade 1,57 (53.3%) in grade 2 and 14 ( 13.1% ) in grade 3. Univariate analysis showed that TIL both before and after radiotherapy was the significant prognostic factor for local pathologic regression ( χ^2= 36.80, P 〈 0.01 ; χ^2=14.00 ,P 〈0.01 ). Kaplan Meier survival analysis showed that TIL and pathologic regression after radiotherapy were significant associated with the snrvival(χ^2=24.00,P 〈0.01 ;χ^2=12.17,P 〈0.01 ). Logistic regression showed that TIL after radiotherapy had a significant effect on local pathologic regression( χ^2= 8.05, P 〈 0.01 ). Condusions For rectal cancer treated with preoperative radiotherapy, TIL before and after radiotherapy is significantly related with local pathologic regression, and TIL after radiotherapy is a prognostic factor.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2009年第3期206-208,共3页 Chinese Journal of Radiation Oncology
关键词 直肠肿瘤/放射疗法 术前放疗 预后 Rectal cancer/radiotherapy Preoperative radiotherapy Prognosis
  • 相关文献

参考文献14

  • 1Murray D, Hreno A, Dutton J, et al. Prognosis in colon cancer: a pathologic reassessment. Arch Surg, 1975,110:908-913.
  • 2Kfisten MD, Henry TL. Tumor infiltration lymphocytes (TILs): lessons learned in 30 years of study. Clinical and applied immunology reviews ,2005,5 : 149-166.
  • 3Jerome G, Anne C, Fatima SC, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science ,2006,313 : 1960-1963.
  • 4Haruo O. Focus on TILs : prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immunity, 2007,7 : 1-9.
  • 5Atreya I, Neurath MF. Immune ceils in colorectal cancer: prognostic relevance and therapeutic strategies. Expert Rev Anticancer Ther ,2008,8:561-572.
  • 6Grabenbauer GG, Lahmer G, Distel L, et al. tumor-infiltrating cytotoxic T ceils but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clinical Cancer Res. 2006, 12 : 3355- 3360.
  • 7Wheeler JMD, Warren BF, Mortensen NJM, et al. Quantification of histologic regression of rectal cancer after irradiation. Dis Colon Rectum ,2002,45 : 1051-1056.
  • 8中国医学科学院肿瘤医院病理科.肿瘤病理学图谱.北京:人民卫生出版社,1975:42.
  • 9Shunyakov L,Ryan CK,Sahasrabudhe DM,et al. The influence of host response on colorectal cancer prognosis. Clin Colorectal Cancer,2004,4:38-45.
  • 10刘建东,杜同海,才又红,王琦,曹修德,郭学恒.局部晚期低位直肠癌术前放化疗的降期效果和加前切除的远期疗效[J].中华放射肿瘤学杂志,2005,14(4):298-301. 被引量:9

二级参考文献29

  • 1Eerol AK, Soini Y, Paakko P. A high number of tumer infiltrating lymphocytes are associated with a small tumor size,low tumor stage, and a favorabale prognosis in operated small cell lung carcinoma[J].Clin Cancer Res, 2000,6(5):1875-1886.
  • 2Norburry cc ,Chambers BJ, Prescott AR, et al. Constitutive macropinocytosis allows TAP-dependent major hisocompatibility Complex Class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells[J]. Eur J Immunol, 1997,27(1):280-291
  • 3Rosenbery SA, Spiess P, Lafreniere R, et al. A new approach to the adoptive immunotherapy of cancer with tumor infiltrating lymphocytes[J].Science,1986,233(9):1233-1318.
  • 4Yang GY, Wagner TD, Thomas CR. Multimodality approaches for rectal cancer. Curr Probl Cancer, 2004,28:311-342.
  • 5Kendal WS, Stern HS. Preoperative chemoradiation for rectal cancer:kudos and a caution. Can J Surg, 2004, 47:87-89.
  • 6Cohen AM, Minsky BD, Schilsky RL. Cancer of the rectum. In:Devita VT, Hellman S, Rosenberg SA. eds. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997.1197-1234.
  • 7Ahmal NR, Nagle D.Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer. Br J Surg, 1997, 84: 1445-1448.
  • 8Theodoropoulos G, Wise WE, Padmanabhan A, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum,2002,45:895-903.
  • 9Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum,2003,46:298-304.
  • 10Crane CH, Skibber JM, Feig BW, et al. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer,2003,97:517-524.

共引文献9

同被引文献24

  • 1郑权,张刚庆,王红兵,高鹏,卿三华.术前放疗与直肠癌术后局部复发的临床观察[J].世界华人消化杂志,2007,15(21):2322-2325. 被引量:7
  • 2Guckenberger M,Eichter A,Krieger T.Is & sin61e &rc sufficient in volumetric-moduI&ted &rc ther&py(VMAT) for complex-sh&ped t&rget volumes[J]. E&diother OncoI, 2009,93(2):259-265.
  • 3Kim JS,Kim NK,Min BS,et aI.Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer:is it beneficial?[J].lnt J Colorectal Dis,2010,25(9):1103-1110.
  • 4M&gne N,Daisne JF,Moretti L.A practice survey of the evolution of rect&l cancer m&n&gementA Belgian Feder&l College of r&diother&py study[J].BuIletin Du C&ncer,2009,79(7):E45-E51.
  • 5NIH consensus conference.Adjuvant ther&py for patients with colon and rect&l cancer[J]. JAMA, 201 O, 264(11 ): 1444-] 450.
  • 6Chang GJ,godriguez-Bigas MA,Eng C,Skibber JM.Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome[J]. Cancer,2009,tl 5(25). 5432-5440.
  • 7Pan CJ,Ziogas A,Buchberg B,et aI.Timing of radiation therapy,lymph node retrieval,and survival in rectal cancer[J].Di$ Oolon Eeetum, 2011,54(5):526-534.
  • 8Sargent DJ,Marsoni S,Monges G,et al.Defective mismatch repair as a predictive marker for tack of efficacy of fluorouracil-based auvant therapy in colon cancer[J].J Olin 0ncol,2010,28(20):3219-3226.
  • 9Hailer DG,Tabernero J,Maroun J,et al. Oapecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage Ill colon cancer[J].J Olin 0ncol,2011,29(11):1465-1471.
  • 10Witlett CG,Duda DG,di Tomaso E,et aI . Efficacy, safety, and biomarkers of neoadjuvant bevacizumab,radiation therapy,and fluorouracil in rectal cancer:a multidisciplinary phase li study[J].J Clin 0ncol,2009, 27(18): 5020-3026.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部